Partisan Management Group Inc.
This article was originally published in Start Up
Executive Summary
The strategy of Partisan Management Group Inc. is simple; reliance on a small circle of talented, experienced friends to build fledgling medical device companies. Led by Norman Weldon, PhD, and Karen Cassidy, it works. Partisan, an early-stage venture capital investment group which focuses strictly on seed funding for medical device start-ups, has produced a series of solid gains for its investors, twice scoring what anyone in the industry would consider to be home runs.
You may also be interested in...
Awaiting The Part D Shakeout
The Medicare drug benefit has more plans and fewer enrollees than expected. That is a recipe for consolidation, but will the federal government wait for the market to evolve?
Upgraded Paige Suite Gains CE-IVD and UKCA Marks
Paige’s AI has obtained CE-IVD and UKCA marks, allowing the launch of a breakthrough product that can spot biomarkers from images.
Sanofi Scores In Second-Line Myeloma But Still In Darzalex’s Shadow
The French company believes it has the best-in-class CD38 antibody with new PFS data, but Johnson & Johnson and Genmab’s Darzalex looks set to retain its advantage in multiple myeloma.